The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Differential epithelial and mesenchymal CTC profiling according to non-small cell lung cancer (NSCLC) molecular subtype.
 
Colin R. Lindsay
No Relationships to Disclose
 
Vincent Faugeroux
No Relationships to Disclose
 
Emma Pailler
No Relationships to Disclose
 
Maria Virginia Bluthgen
No Relationships to Disclose
 
Chloe Pannet
No Relationships to Disclose
 
Maud Ngo-camus
No Relationships to Disclose
 
Guillaume Bescher
No Relationships to Disclose
 
Esperanza Perez
No Relationships to Disclose
 
Caroline Caramella
No Relationships to Disclose
 
Fanny Billiot
No Relationships to Disclose
 
Jordi Remon
No Relationships to Disclose
 
David Planchard
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi
Research Funding - Novartis (Inst)
 
Jean-Charles Soria
Honoraria - AstraZeneca/MedImmune; Merus; MSD Oncology; Pfizer; Roche/Genentech; Symphony Evolution
 
Benjamin Besse
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Inivata (Inst); Lilly (Inst); Onxeo (Inst); ose pharma (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Medarex; Novartis; Pfizer; Pierre Fabre; Roche
 
Françoise Farace
No Relationships to Disclose